Mechanisms of Synergistic Regulation of Stem/Progenitors
Mechanisms of Synergistic Regulation of Stem/Progenitors
批准号:
6918472
负责人:
HAL E. BROXMEYER
金额:
$37.88万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-04-01 至 2009-03-31
关键词:
biological signal transductioncell cell interactioncell cyclecell growth regulationcell proliferationcytokinecytokine receptorsgenetically modified animalshematopoiesishematopoietic stem cellshuman tissuelaboratory mousemitotic spindle apparatusmyeloid stem celloncoprotein p21pluripotent stem cellsprotein structure functionstem cell factortissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hematopoiesis is regulated by interacting cytokines that act on proliferation of hematopoietic stem cells (HSC) and myeloid progenitor cells (MPC) and on self-renewal of HSC. We identified novel selective actions in vitro and in vivo of IL-20 on proliferation of multipotential myeloid progenitor cells (CFU-GEMM) when used in combination with SCF, and have preliminary data showing IL-20 enhancement of competitive HSC in vivo. We believe that synergistic interactions are critical for normal maintenance and production of blood cells, and hypothesize that IL-20, alone or in combination with SCF, and perhaps other cytokines, will enhance proliferation of HSC and may be involved in the regulation of self-renewal of HSC. We consider cell cycle regulation and cell cycle checkpoints critical for correct regulation of proliferation and self-renewal of HSC, and hypothesize, based on our studies on SCF regulation of cell cycle asymmetry, and on p21cip1/waf1 monitoring of microtubule checkpoints, that the mitotic spindle assembly checkpoint (MSAC) is intimately involved in, and necessary for normal proliferation and self-renewal of HSC. We believe that the effects of p21cip1/waf1 on HSC, are at least in part mediated through the MSAC. We also hypothesize that the effects of IL-20, in combination with SCF on MPC and on HSC are mediated in part through p21cip1/waf1 and the MSAC. Our long term goals are to define cytokine effects that modulate proliferation and self-renewal of HSC for clinical benefit. Towards these goals we propose the following aims: 1. Evaluate effects of IL-20 and SCF, alone and in combination, on proliferation of HSC and MPC, and on self-renewal of HSC. 2. Determine mechanisms of action of IL-20 alone and in combination with other cytokines on cell proliferation and/or self-renewal of HSC and the potential roles of p21cip1/waf1, StatS, Wnt-GSK-3 pathway and SOCS in mediating these actions. 3. Elucidate the role of MSAC in proliferation of HSC and MPC, and in self-renewal of HSC, and link these effects to cytokine actions on these functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease
-
批准号:10219824
-
项目类别:
-
资助金额:$76.81万
-
财政年份:2018
-
负责人:HAL E. BROXMEYER
-
依托单位:
DEK Regulation of Hematopoietic Stem Cell Renewal, Fate, and Hematopoiesis
-
批准号:9476237
-
项目类别:
-
资助金额:$49.9万
-
财政年份:2016
-
负责人:HAL E. BROXMEYER
-
依托单位:
Administrative Core
-
批准号:10473853
-
项目类别:
-
资助金额:$7.51万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hypoxia Core
-
批准号:10473863
-
项目类别:
-
资助金额:$13.67万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hypoxia Core
-
批准号:10681262
-
项目类别:
-
资助金额:$14.29万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
-
批准号:10201069
-
项目类别:
-
资助金额:$23.95万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
-
批准号:9987195
-
项目类别:
-
资助金额:$1.97万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Administrative Core
-
批准号:10206538
-
项目类别:
-
资助金额:$15.44万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hypoxia Core
-
批准号:10206541
-
项目类别:
-
资助金额:$15.44万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Administrative Core
-
批准号:10681256
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
-
批准号:9752987
-
项目类别:
-
资助金额:$91.95万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
-
批准号:9325311
-
项目类别:
-
资助金额:$94.85万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
-
批准号:8972225
-
项目类别:
-
资助金额:$99.53万
-
财政年份:2015
-
负责人:HAL E. BROXMEYER
-
依托单位:
Enhancing Engraftment of Cord Blood by CD26 Inhibition
-
批准号:8670014
-
项目类别:
-
资助金额:$72.7万
-
财政年份:2012
-
负责人:HAL E. BROXMEYER
-
依托单位:
Enhancing Engraftment of Cord Blood by CD26 Inhibition
-
批准号:8424273
-
项目类别:
-
资助金额:$71.61万
-
财政年份:2012
-
负责人:HAL E. BROXMEYER
-
依托单位:
Enhancing Engraftment of Cord Blood by CD26 Inhibition
-
批准号:8813618
-
项目类别:
-
资助金额:$72.03万
-
财政年份:2012
-
负责人:HAL E. BROXMEYER
-
依托单位:
Enhancing Engraftment of Cord Blood by CD26 Inhibition
-
批准号:8219617
-
项目类别:
-
资助金额:$76.06万
-
财政年份:2012
-
负责人:HAL E. BROXMEYER
-
依托单位:
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
-
批准号:8150918
-
项目类别:
-
资助金额:$71.74万
-
财政年份:2010
-
负责人:HAL E. BROXMEYER
-
依托单位:
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
-
批准号:8505009
-
项目类别:
-
资助金额:$70.75万
-
财政年份:2010
-
负责人:HAL E. BROXMEYER
-
依托单位:
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
-
批准号:8296358
-
项目类别:
-
资助金额:$75.02万
-
财政年份:2010
-
负责人:HAL E. BROXMEYER
-
依托单位:
海外基金